Lin Sue-Jean insider trades
Lin Sue-Jean has filed 8 Form 4s with the SEC that we hold, for Arcutis Biotherapeutics, Inc. (ARQT) (Director) and Stevanato Group S.p.A. (STVN) (Director). Across all of them we count 0 purchases worth $0 and 2 sales worth $898.5K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($898.5K). The largest single trade was a sale of 25,272 shares of Arcutis Biotherapeutics, Inc. worth $777.9K, dated 2025-11-24. The first filing on our record is dated 2022-06-03 and the latest 2026-06-26.
Arcutis Biotherapeutics, Inc. (ARQT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-11-24 | S, sale reported on Form 4 | 25,272 | $777.9K | 2025-11-25 |
| 2026-06-15 | S, sale reported on Form 4 | 4,946 | $120.6K | 2026-06-17 |
Stevanato Group S.p.A. (STVN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1867788) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms